Answer
Thrombocytopenia, decreased haemoglobin and decreased neutrophils have been observed during tedizolid phosphate treatment, with most thrombocytopenia cases occurring during treatment longer than the recommended duration.
Sources for this answer
- Sivextro 200 mg powder for concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 15Document updated
Sources checked